MRNA Today - Jul 09: Morgan Stanley Neutral Rating

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

MRNA Today - Jul 09: Morgan Stanley Neutral Rating

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor. I’ve been in the game for a while, and today I’m breaking down what went down with Moderna, or MRNA. Spoiler alert: it was a red day for them, dropping about 3.5%. Oof.

So, here’s the scoop. MRNA opened the day looking pretty decent, but then it got smoked after Morgan Stanley decided to stick with a neutral rating. Even though they lifted their price target, that didn’t really pump up the stock. People hit the sell button fast, and the shares took a dive. It’s like everyone just decided they weren’t feeling it anymore.

Now, let’s talk about the why. Morgan Stanley’s move was kinda surprising to folks since there was some buzz around Moderna lately. They had that big six-day winning streak, right? But then, after appointing a new board member and retreating from a 52-week high, it seems investors got a little jittery. Plus, there’s that whole S&P 500 loser title they snagged today, which doesn't help the vibe. It’s like the stock is trying to find its footing, but the market’s just not having it right now.

Looking ahead, Moderna’s got a results call coming up on July 31. That could be a big moment for them. Investors will be tuning in to see what’s next, especially after all the back and forth lately.

Alright, that’s the rundown! Just remember, I’m here to keep you in the loop, not to tell you what to do with your cash. Keep it chill, and I’ll catch you later!

まだレビューはありません